Outcomes of Patients with Light Chain Amyloidosis who had Autologous Stem Cell Transplantation with Three or more Organs Involved.

BACKGROUND: Prior reports suggested that three or more organ involvement is a contraindication for autologous stem cell transplant (ASCT) in light chain amyloidosis (AL). Therefore, most centers limit transplantation to patients who have no more than two organs significantly involved. METHODS: We re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Al Saleh, Abdullah S., Sidiqi, M Hasib, Muchtar, Eli, Dispenzieri, Angela, Buadi, Francis K., Dingli, David, Lacy, Martha Q., Warsame, Rahma M., Gonsalves, Wilson I., Kourelis, Taxiarchis V., Hogan, William J., Hayman, Suzanne R., Kapoor, Prashant, Kumar, Shaji K., Gertz, Morie A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698422/
https://ncbi.nlm.nih.gov/pubmed/31054986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.04.024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi